Product Information
OMEPRAZOLE-BICARB 40-1,680 PKT is a generic product labeled by Ajanta Pharma USA Inc., priced at $7.9041 per EA under NDC 27241003062. Its NADAC has been published 205 times since Oct 2, 2019.
FDA first approved this application on Jul 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40; 1680 mg/1; mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241003062
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLE; SODIUM BICARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA205545FDA Approved
7/27/2016
TE Code
AB
On Market Since
7/27/2016
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has been published 205 times since Oct 2, 2019, and over the history we have for it it has declined 56.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9041 per EA |
|---|---|
| All-time high | $18.5163 (Nov 11, 2020) |
| All-time low | $7.9041 (Sep 23, 2026) |
| 52-week high | $10.2732 |
| 52-week low | $7.9041 |
| Median price | $13.1759 |
| Average price | $13.6192 |
| Largest weekly change | -28.8% (Dec 20, 2023) |
| Weeks tracked | 205 |
| Tracking since | Oct 2, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole and Sodium Bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE-BICARB 40-1,680 PKT?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 40-1,680 PKT, manufactured by Ajanta Pharma USA Inc., is $7.9041 per EA (NDC 27241003062), effective Sep 30, 2026.
How has the price of OMEPRAZOLE-BICARB 40-1,680 PKT changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has declined 56.2%. It has been tracked across 205 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 40-1,680 PKT?
Since Oct 2, 2019, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has ranged from a low of $7.9041 (Sep 23, 2026) to a high of $18.5163 (Nov 11, 2020), with a median of $13.1759 per EA.
Are there cheaper alternatives to OMEPRAZOLE-BICARB 40-1,680 PKT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OMEPRAZOLE-BICARB 40-1,680 PKT in a comparable dosage form, but none are currently priced below it.
Who manufactures OMEPRAZOLE-BICARB 40-1,680 PKT?
OMEPRAZOLE-BICARB 40-1,680 PKT (NDC 27241003062) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.